Neuromod has developed Lenire®, an at-home tinnitus treatment technology that is prescribed and customised on a per patient basis by qualified healthcare providers. Lenire is CE-marked in Europe and approved by the US Food and Drug Administration through the award of a De Novo Grant.
A lightweight, handheld device that controls the timing, intensity and synchronisation of the sound and tongue stimuli.
This is a proprietary intra-oral device, ergonomically designed to sit comfortably in the closed mouth. Tiny electrodes on the surface of the Tonguetip® deliver mild and safe energy pulses to the surface of the tip of the tongue.
Bluetooth headphones deliver customised paired sound stimuli to the auditory nerve.
Visit www.lenire.com to find out more